Theacrine

Best Price Available

Overview

Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid structurally related to caffeine, found naturally in Camellia assamica var. kucha — a tea cultivar grown in southern China and northern Vietnam — and in smaller amounts in Cupuaçu (Theobroma grandiflorum) seeds. It shares caffeine's xanthine backbone but carries an extra methyl group at the 9-position and a 2,6,8-trione oxidation pattern, giving it pharmacology that overlaps caffeine's adenosine-receptor antagonism while diverging in dopaminergic tone and tolerance development. The most widely studied form in human trials is the patented ingredient TeaCrine, a ≥98% pure synthetic equivalent used in most commercial nootropic and pre-workout formulas. The practical appeal of theacrine in community use rests on three observations: first, healthy adults taking 200-300 mg daily report stimulation subjectively comparable to 150-200 mg caffeine — but with less jitter, less heart-rate elevation, and a slower onset (~60-90 minutes) that many users describe as "smoother" than caffeine's 20-40 minute peak. Second, an 8-week daily-dosing study (Taylor 2016, PMID 27335344) found no meaningful development of tolerance at 200-300 mg/day, no withdrawal signs on cessation, and no shifts in resting heart rate, blood pressure, liver enzymes, or complete blood count — a tolerance profile that genuinely differs from caffeine, where habitual use produces documented receptor upregulation and dependence within 1-2 weeks. Third, co-administration with caffeine produces synergy: pharmacokinetic data (He 2017, PMID 28356193) show caffeine roughly doubles theacrine plasma exposure (AUC), likely by slowing hepatic clearance, so 125 mg theacrine + 150 mg caffeine often outperforms either compound alone for perceived focus and endurance. Mechanism is not identical to caffeine. Like caffeine, theacrine antagonizes adenosine A1 and A2A receptors (the primary driver of wakefulness and reduced perception of effort), but rodent models (Feduccia 2012, PMID 22771692) additionally show dose-dependent increases in nucleus accumbens dopamine and locomotor activation that are blocked by both adenosine and dopamine-D1 antagonists — suggesting a dual adenosinergic-dopaminergic mechanism that caffeine does not fully replicate. This may explain the "motivation" quality users report and the absence of downregulation: chronic adenosine blockade alone should produce tolerance, but the concurrent dopaminergic signal appears to counterbalance receptor adaptation over an 8-week horizon. Human clinical data are limited but consistent. A double-blind crossover in habitual caffeine users (Ziegenfuss 2017, PMID 28280478) showed 300 mg theacrine improved reaction-time Bond-Lader alertness scores without the jitter-axis elevation that 150 mg caffeine produced in the same subjects. A separate 8-week safety and efficacy trial in 60 adults (Kuhman 2015, PMID 26569270) reported significant improvements in self-rated energy, focus, and concentration versus placebo at 200 and 300 mg/day with no adverse clinical findings. Community-tier evidence (r/Nootropics, forum writeups spanning 2015-2024) tends to converge on 100-200 mg as a mild-stim daily baseline, 250-300 mg for pre-workout or high-focus sessions, and 150 mg + 100 mg caffeine as a common synergy stack. Most users who transition from pure caffeine report similar energy with substantially less afternoon "crash" and easier sleep onset if taken before 2 PM. Practical considerations: theacrine is sold as a food-supplement ingredient in the US, EU, Australia, and most of Asia. It is NOT a controlled substance, not a prescription drug, and has no abuse liability signal in animal models. Quality matters — the vast majority of peer-reviewed human data used TeaCrine, a standardized ≥98% pure ingredient; some generic "theacrine" bulk powder has been found to be underdosed or contaminated with caffeine (independent COA testing, 2019-2021). Look for products that explicitly cite the TeaCrine trademark and provide a certificate of analysis. Theacrine is often stacked with L-theanine (100-200 mg) for an anxiolytic counterweight, with alpha-GPC (300 mg) for cholinergic contrast, and with dynamine (methylliberine, a faster-acting but shorter-duration analog) for a biphasic energy curve. It is not recommended for pregnancy, breastfeeding, uncontrolled hypertension, or anyone on MAOIs. The safety window at studied doses is wide, but the long-term profile beyond 8 weeks remains formally uncharacterized — community experience over 2-3 years of daily use suggests it holds up, but this is self-report data.

Contraindications

Research Disclaimer

This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.

$39.99

up to $75.00

—

1

4

pouch, other, topical

Sign in to leave a review

Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with Theacrine.

Best Price

Well-researched compound